FDA Grants Orphan Drug Designation to Biostar Pharma's Utidelone for Pancreatic Cancer ...

Retrieved on: 2025-09-25 15:07:24

Tags for this article:

Food and Drug Administration

Biotechnology law

Drug discovery

Orphan drug

Pharmaceuticals policy

Investigational New Drug

Pharmaceutical industry

Biostar Pharma Inc.

Mark Chiang

u.s. food and drug administration

Click the tags to see associated articles and topics

FDA Grants Orphan Drug Designation to Biostar Pharma's Utidelone for Pancreatic Cancer .... View article details on hiswai:

Excerpt

Biostar Pharma, Inc., a subsidiary of Beijing Biostar Biopharmaceutical Co., Ltd., specializes in synthetic biology-driven biopharmaceutical research ...

Article found on: www.geneonline.com

View Original Article